Literature DB >> 22037021

Extracellular HspBP1 inhibits formation of a cytotoxic Tag7-Hsp70 complex in vitro and in human serum.

Denis V Yashin1, Elena A Dukhanina, Olga D Kabanova, Elena A Romanova, Tamara I Lukyanova, Alexsander G Tonevitskii, Alexey A Belogurov, Deborah A Raynes, Anton A Sheludchenkov, Nikolai V Gnuchev, Vince Guerriero, Georgii P Georgiev, Lidia P Sashchenko.   

Abstract

Tag7 (PGRP-S) was described as an innate immunity protein. Earlier we have shown that Tag7 forms with Hsp70 a stable complex with cytotoxic and antitumor activity. The same complex is formed in and secreted by cytotoxic T-lymphocytes. We have also found that Hsp-binding protein HspBP1 incapacitates the Tag7-Hsp70 complex. Here we have studied the interaction of extracellular Tag7 and HspBP1. We have shown that HspBP1 binds Tag7 in the conditioned medium of tumor CSML0 cells, thereby preventing formation of the cytotoxic Tag7-Hsp70 complex. We have also found that Tag7, if present in serum (in every third donor on average), is always in complex with HspBP1. This may be a protective measure against indiscriminate attack of the cytotoxic complex on normal cells.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037021     DOI: 10.1016/j.biochi.2011.10.007

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  2 in total

1.  A new role for PGRP-S (Tag7) in immune defense: lymphocyte migration is induced by a chemoattractant complex of Tag7 with Mts1.

Authors:  E A Dukhanina; T I Lukyanova; E A Romanova; V Guerriero; N V Gnuchev; G P Georgiev; D V Yashin; L P Sashchenko
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form.

Authors:  Huiming Yang; Su Yang; Liang Jing; Luoxiu Huang; Luxiao Chen; Xianxian Zhao; Weili Yang; Yongcheng Pan; Peng Yin; Zhaohui S Qin; Beisha Tang; Shihua Li; Xiao-Jiang Li
Journal:  Nat Commun       Date:  2020-05-22       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.